The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Primary ipilimumab/nivolumab followed by adjuvant nivolumab in patients with locally advanced or oligometastatic melanoma: Update on outcome.
 
Emilia Cocorocchio
Consulting or Advisory Role - Bristol-Myers Squibb
Speakers' Bureau - Novartis; Roche
 
Sara Gandini
No Relationships to Disclose
 
Luigi Nezi
No Relationships to Disclose
 
Teresa Manzo
No Relationships to Disclose
 
Luca Mazzarella
Honoraria - Thetis Pharma
 
Massimo Barberis
Consulting or Advisory Role - Amgen; MSD; Roche; Thermo Fisher Scientific
Speakers' Bureau - MSD; Roche; Thermo Fisher Scientific
 
Luisa Lanfrancone
No Relationships to Disclose
 
Laura Pala
No Relationships to Disclose
 
Fabio Conforti
No Relationships to Disclose
 
Elisabetta Pennacchioli
No Relationships to Disclose
 
Gianmarco Orsolini
No Relationships to Disclose
 
Maria Teresa Fierro
Travel, Accommodations, Expenses - Abbvie; Bristol-Myers Squibb; Roche
 
Pietro Quaglino
No Relationships to Disclose
 
Rebecca Senetta
No Relationships to Disclose
 
Virginia Caliendo
No Relationships to Disclose
 
Concetta Riviello
No Relationships to Disclose
 
Sara Stucchi
No Relationships to Disclose
 
Angeli Dominique Macandog
No Relationships to Disclose
 
Gianmaria Frige
No Relationships to Disclose
 
Pier Francesco Ferrucci
Expert Testimony - Delcath Systems